Related Experiment Video

Updated: Mar 1, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

4.9K

Adherence to Hepatitis B Antiviral Therapy: A Qualitative Study

Suzanne Polis1, Iryna Zablotska-Manos, Amany Zekry

  • 1Suzanne Polis, MPH (research), BN, RN, is Senior Research Fellow (Nursing), Nursing Research & Practice Development Unit, The Sydney Children's Hospitals Network, Randwick New South Wales, Australia. Iryna Zablotska-Manos, PhD, BSc, is Senior Lecturer, The Kirby Institute, UNSW Australia, Wallace Wurth Building, Sydney NSW, Australia. Amany Zekry, PhD, MBBS, is Associate Professor and Hepatologist, St George Hospital, Department of Gastroenterology, Kogarah, New South Wales, Australia, and St George Hospital Clinical School of Medicine, UNSW, Australia. Lisa Maher, PhD, is Professor and Program Head and NHMRC Senior Research Fellow, Viral Hepatitis Epidemiology and Prevention Program Kirby Institute, UNSW Australia, Wallace Wurth Building, Sydney New South Wales, Australia.

Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates
|June 2, 2017
PubMed
Summary

Adherence to Hepatitis B virus (HBV) antiviral therapy is crucial for suppressing viral load. Key factors influencing adherence include patient-clinician communication, disease knowledge, routine, and fear of progression.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.7K
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

14.0K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
193